Osaic Holdings’s HCW Biologics HCWB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9 Buy
5
+1
+25% +$3 ﹤0.01% 8027
2026
Q2
$20 Hold
4
– – ﹤0.01% 7923
2026
Q1
$9 Hold
4
– – ﹤0.01% 7746
2025
Q4
$25 Hold
4
– – ﹤0.01% 7728
2025
Q3
$96 Hold
4
– – ﹤0.01% 7748
2025
Q2
$103 Hold
4
– – ﹤0.01% 7564
2025
Q1
$285 Buy
+4
New +$352 ﹤0.01% 7112

Other funds holding HCWB

Osaic Holdings's HCWB Position: Q3 2026 in Review

Osaic Holdings increased its HCW Biologics (HCWB) stake by 25% in Q3 2026, buying an estimated $3 and bringing the position to 5 shares worth $9. The position accounts for ﹤0.01% of the portfolio, ranked #8027.

Osaic Holdings first reported a position in HCWB in Q1 2025 and has held it in 7 quarters since. The position peaked at $285 in Q1 2025. 8 funds tracked by Wall St. Rank hold HCWB as of Q3 2026.

  • Osaic Holdings held 5 shares of HCW Biologics worth $9 as of Q3 2026.
  • Osaic Holdings bought 1 HCW Biologics share in Q3 2026, an estimated $3.
  • HCW Biologics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #8027 holding.
  • Osaic Holdings first reported a position in HCW Biologics in Q1 2025 and has held it in 7 quarters since.
  • Osaic Holdings's HCW Biologics position peaked at $285 in Q1 2025.
  • 8 funds tracked by Wall St. Rank held HCW Biologics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.